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ariations in venous thromboembolism (VTE) prevention in hip
racture: results from a multicentre audit in the UK
. Masud, A. Sahu, G. Cook, B.D. Todd
Stepping Hill Hospital, Stockport, UK
Introduction:Wepresent theﬁndings of theNorthWest regional
ip fracture audit and correlate these with the available clinical
uidelines on VTE prevention.
Methods: Between April and July 2007 all hip fracture patients
dmitted to 1 of 14 hospitals had their data prospectively collected.
e analysed the data with respect to VTE prophylaxis.
Results: There were 1010 patients. Overall, 53% of patients had
nly chemical prophylaxis, 6% had only mechanical, 37% had both
ypes, and 4% had none. There was considerable variation amongst
ospitals in this region. LMWHwas themost frequentlyused chem-
cal prophylaxis agent (>90% of cases). Fondaparinux, aspirin, and
arfarin were also used but in <10% of cases of chemical prophy-
axis. Graduated compression stockings (GCS) were used alone in
7% of cases of mechanical prophylaxis. Chemical prophylaxis was
topped on discharge in nine hospitals. Where aspirin was used,
his was continued in the community for a total of 6 weeks.
Discussion: During the audit period various guidelines were
vailable for prophylaxis against VTE. The SIGN guidelines rec-
mmended that all hip fracture patients should receive aspirin as
he primary method of chemical prophylaxis, and this should be
ontinued for 35 days. Heparins should be reserved for selected
atients at high risk of VTE due to multiple risk factors. They found
o evidence for the use of GCS. The ACCP guidelines recommend
he routine use of fondaparinux, LMWH, warfarin, or low-dose
nfractionated heparin. They strongly recommend against the use
f aspirin alone. Thromboprophylaxis should be continued for up
o 35 days. Mechanical methods should be used if chemical agents
re contraindicated. Since commencing this audit the NICE guide-
ines on VTE have been published. These recommend that all hip
racture patients receive mechanical prophylaxis with at least GCS.
his should be supplemented with LMWH or fondaparinux in all
atients, and be continued for 4 weeks. The BOA published its
uidelines on the management of fragility fractures in September
007. These warn against the routine use of chemical prophylaxis
572-3461  Copyright © 2013 Published by Elsevier Ltd. Open access under the Elsevierin hip fracture patients and recommend early surgery and immedi-
ate post-operative mobilisation to reduce the incidence of clinical
VTE.
Conclusion: There is conﬂicting guidance available to
orthopaedic surgeons on VTE prevention in hip fracture patients.
This is reﬂected in the considerable variation in clinical practice
seen in this regional audit. There is a need for clear and com-
prehensive evidence-based guidelines speciﬁc to orthopaedic
surgery.
doi:10.1016/j.injury.2010.07.324
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What is the best management for patients on clopidogrel with
a fractured neck of femur?
I. Nwachuku, M. Jones, T. Clough [Wrightington]
Wrightington Hospital, Orthopaedics, Wrightington, United Kingdom
Introduction and aims: This study aims to assess the differences
in blood loss, length of stay and mortality in patients suffering a
proximal femur fracture whilst on antiplatelets such as clopidogrel
or dipyridamole. We compare the outcome in patients managed
with early versus late surgery, along with the difference between
the techniques of surgery. We note the lack of literature guidance
in this patient group.
We performed a retrospective observational study of 548 neck
of femur fracture patients during 2008–2009 admitted to the
orthopaedic trauma unit at Wrightington, Wigan and Leigh NHS
trust (UK) over a 20-month period. 31 patients were identiﬁed
as taking clopidogrel on admission and 3 were taking dipyri-
damole. Data was collected on pre-operative management, timing
of surgery, operation performed, intra-operative complications
post-operative complications, length of hospital stay andmortality.
Findings: Of 31 patients admitted on clopidogrel or dipyri-
damole, 28 were on clopidogrel while 3 were on dipyridamole, 4
patients were managed non-operatively and 8 patients were dead
at 12 months. 7 patients were on a combination of anti-platelet
medication (including asprin), 24 (88%) patients had clopidogrel
stopped pre-operatively, while the dipyridamole was not stopped
in any patient.
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